Skip to main content
OpenTrials

Clinical trial condition

Retinal Diseases

Explore clinical trials studying Retinal Diseases. Study availability and eligibility vary by location and protocol.

2,349 public trials 291 recruiting studies
Refine in advanced search Browse all conditions

Retinal Diseases trial results

Completed

To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema

NCT04058067

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shantou, Guangdong, China
  • Novartis Investigative Site Harbin, Heilongjiang, China
  • Novartis Investigative Site Wuhan, Hubei, China
View all 24 locations
View Trial Details
Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

NCT04597632

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Fort Lauderdale, Florida, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
  • Novartis Investigative Site Minneapolis, Minnesota, United States
View all 60 locations
View Trial Details
Completed

A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

NCT04239027

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +9 more
Locations
  • Novartis Investigative Site Nice, Cedex1, France
  • Novartis Investigative Site Rennes, FRA, France
  • Novartis Investigative Site Saint-Cyr-sur-Loire, Indre Et Loire, France
  • Novartis Investigative Site Lyon, Rhone, France
View all 40 locations
View Trial Details
Completed

Clinical Study to Compare Efficacy and Safety of AVT06 and EU-Eylea (ALVOEYE)

NCT05155293

Conditions
Eye Diseases, Eye Diseases, Hereditary, Macular Degeneration, +3 more
Locations
  • Nemocnicni lekarna Sokolov Sokolov, Czechia
  • JSC Evex Medical Corporation Tbilisi, Georgia
  • Keneikai Hayashi Eye Hospital Fukuoka, Japan
  • Riga East University Hospital Clinical Centre "Bikernieki" Riga, Latvia
View Trial Details
Completed

Six-months Versus Nine-months ATT for Ocular TB

NCT06613919

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • University of Medicine Magway, EENT Hospital Nay Pyi Taw, Burma
  • LV Prasad Eye Institute Bhubaneswar, Odisha, India
  • Ramathibodi Hospital, Mahidol University Bangkok, Thailand
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

NCT04265261

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +6 more
Locations
  • Arizona Retina and Vitreous Consultants Phoenix, Arizona, United States
  • Retina Associates Tucson Tucson, Arizona, United States
  • Win Retina Arcadia, California, United States
  • Global Research Management Glendale, California, United States
View all 68 locations
View Trial Details

Related conditions